GlassScriptPhysician profile
Lauren A Cottingham
NPI 1699237263
$1,904.10
in general payments reported to CMS, 2019-2025
22 companies · $927 in 2025
The $927 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $335 · 2023: $603 · 2024: $39.21 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $626.68 | 2022-2025 | |
| Edwards Lifesciences Corporation | $190.42 | 2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $135.93 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $134.17 | 2022-2023 | Xarelto |
| Amgen INC. | $126.40 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $95.21 | 2022-2025 | Farxiga, Brilinta |
| Pfizer INC. | $92.49 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $88.00 | 2022-2023 | |
| Novo Nordisk INC | $58.51 | 2023-2025 | Wegovy, Ozempic |
| Cvrx, INC. | $50.81 | 2023 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $45.57 | 2023 | Evkeeza |
| Alnylam Pharmaceuticals INC. | $38.33 | 2022-2023 | Onpattro |
| Stryker Corporation | $35.67 | 2025 | Intri24 Introducer Sheath |
| Abbott Laboratories | $31.53 | 2022-2023 | Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $23.59 | 2025 | |
| Cordis US Corp. | $21.00 | 2022 | |
| Boston Scientific Corporation | $19.22 | 2025 | Watchman Flx |
| Teleflex LLC | $16.70 | 2025 | Trapliner |
| Actelion Pharmaceuticals US, INC. | $15.00 | 2023 | Uptravi, Opsumit |
| Kestra Medical Technology Services, INC. | $14.29 | 2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $13.63 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Cottingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.